Predictors of hospital mortality in the global registry of acute coronary events

Granger, C.B.; Goldberg, Robert J.; Dabbous, O.

doi:10.1016/j.accreview.2003.12.013

Cited by 366 publications

(589 citation statements)

References 0 publications

Supporting

Mentioning

538

Contrasting

Unclassified

Order By: Relevance

“…The populations in the trial were randomly selected. The in hospital model was based upon data from 11,389 patients with either STEMI or a NSTEMI (Granger et al, 2006). The model was then validated based on data from an additional 3,972 patients from GRACE and 12,142 patients from the GUSTO 11b trial.…”

Section: Resultsmentioning

confidence: 99%

“…Some of the most robust clinical prediction tools have been developed in selected populations of patients with STEMI (Granger et al, 2006;Ramsay, Podogrodzka, McClure, & Flox, 2007). This paper will identify the secondary clinical risk assessment prediction models and compare their psychometric properties in the ACS population with a focus on their use in the PCI era for STEMI patients.…”

Section: Cadillac Secondary Cardiovascular Risk Scorementioning

confidence: 99%

“…Male gender made up 73% of the CADILLAC trial and 74.8% of the PAMI trial. The ethnicity of the samples of the two trials used to derive the score was: CADILLAC -patients were enrolled in 76 centers in nine countries ; PAMI -62 sites in several countries (Granger et al, 2006). Table 2 summarizes the CADILLAC risk scoring tool.…”

Section: Pami Secondary Cardiovascular Risk Scorementioning

confidence: 99%

See 2 more Smart Citations

Assessing risk post intervention for an acute coronary syndrome: A review of the risk assessment tools and their development

Scruth¹,

Worrall‐Carter²,

Cheng³

et al. 2012

Contemporary Nurse

View full text Add to dashboard Cite

Considerable variability in survival rate after an acute myocardial infarction exists and accurate risk stratification is of significant importance. The American College of Cardiology and the American Heart Association has recommended early risk stratification using several clinical risk scoring instruments to identify high risk patients. The aim of this paper is to identify secondary cardiovascular risk scoring instruments that could be utilized at the time of intervention for acute coronary syndromes and compare their psychometric properties as they were developed. A search using Medline, Cumulative Index to Nursing and Allied Health Literature and the Psychology and Behavioral Sciences Collection databases identified studies published between January 1990 and January 2010 used to measure risk after intervention for acute coronary syndrome. Four validated secondary risk prediction scoring instruments were identified for comparison. Secondary risk prediction scoring instruments for the acute coronary syndrome patient population are evidence based, valid and reliable. Use of the instruments by cardiac focused clinicians will aid in the determination of treatment strategies, and estimation of short and long term events and mortality.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Cadillac Secondary Cardiovascular Risk Scorementioning

confidence: 99%

Section: Pami Secondary Cardiovascular Risk Scorementioning

confidence: 99%

See 1 more Smart Citation

Assessing risk post intervention for an acute coronary syndrome: A review of the risk assessment tools and their development

Scruth¹,

Worrall‐Carter²,

Cheng³

et al. 2012

Contemporary Nurse

View full text Add to dashboard Cite

show abstract

“…The protocol was approved by our local Review Board Committee. GRACE score 2.0 was calculated for all the patients of the study [2].…”

Section: Methodsmentioning

confidence: 99%

“…Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) represents a prevalent and heterogeneous population with a broad spectrum of outcomes [2].…”

Section: Introductionmentioning

confidence: 99%

Single spot albumin to creatinine ratio: A simple marker of long-term prognosis in non-ST segment elevation acute coronary syndromes

et al. 2016

View full text Add to dashboard Cite

Background: Microalbuminuria is a known risk factor for cardiovascular morbidity and mortality suggesting that it should be a marker of endothelial dysfunction. Albumin to creatinine ratio (ACR) is an available and rapid test for microalbuminuria determination, with a high correlation with the 24-h urine collection method. There is no prospective study that evaluates the prognostic value of ACR in patients with non ST-segment elevation acute coronary syndromes (NSTE-ACS). The purpose of our study was to detect the long-term prognostic value of ACR in patients with NSTE-ACS. Methods: Albumin to creatinine ratio was estimated in 700 patients with NSTE-ACS at SE 0.04, 2 p = 0.03, with a good calibration with both models. Conclusions: Albumin to creatinine ratio is an independent and accessible predictor of long-term adverse outcomes in NSTE-ACS, providing additional value for risk stratification. (Cardiol J 2016; 23, 3: 236-241)

show abstract

Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction

Zeller¹

2005

Arch Intern Med

153

View full text Add to dashboard Cite

show abstract

Predictors of hospital mortality in the global registry of acute coronary events

Cited by 366 publications

References 0 publications

Assessing risk post intervention for an acute coronary syndrome: A review of the risk assessment tools and their development

Assessing risk post intervention for an acute coronary syndrome: A review of the risk assessment tools and their development

Single spot albumin to creatinine ratio: A simple marker of long-term prognosis in non-ST segment elevation acute coronary syndromes

Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction

Contact Info

Product

Resources

About